Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 



DoD Breast Cancer Research Program Funding Opportunities

Applications to the FY18 BCRP are being solicited for the DHA. The BCRP supports innovative, high-impact research focused on ending breast cancer. 

• Breakthrough Award Level 1 & 2: Supports promising research that has the potential to lead to or make breakthroughs in breast cancer. LOI Due: November 1, 2018



Prostate Cancer Research Program Funding Opportunities 

The mission of the PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all men experiencing the impact of the disease.

    Health Disparity Research Award – Letter of Intent Due: September 20, 2018
    Health Disparity Scholar Award – Letter of Intent Due: September 20, 2018

http://cdmrp.army.mil/funding/pcrp


Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)

The over-arching goal of this NCI R25 program is to support educational activities that enhance the diversity of the nation's biomedical, behavioral, and clinical research workforce.

Application Deadline: September 25, 2018



Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)

The over-arching goal of this NCI R25 program is to support educational activities that enhance the diversity of the nation's biomedical, behavioral, and clinical research workforce.

Application Deadline: September 25, 2018



Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)

This FOA encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes.

Application Deadline: October 5, 2018


Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional)

The purpose of this FOA is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN).  The RDCRCs are intended to advance the diagnosis, management, and treatment of rare diseases with a focus on clinical trial readiness.  

Application Deadline: October 9, 2018

 

Obesity Policy and Program Evaluation

This FOA establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors and/or weight outcomes in an effort to prevent or reduce obesity.

Application Deadlines :

September 13, 2018; October 10, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-854.html



Administrative Supplements for Research on Dietary Supplements

This FOA announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. 

Application Deadline: October 15, 2018

 

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents

This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods.

Application Deadline: October 15, 2018



Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01/R21)

The purpose of this FOA is to support basic research examining how Electronic Nicotine Delivery Systems (ENDS) aerosols affect normal and disease states relevant to human cells, tissues and organs.

Application Deadline: October 24, 2018


NCCN/Eli Lilly and Company Quality of Care in Gastric Cancer Request for Proposals

NCCN® and Eli Lilly are collaborating to offer a new opportunity seeking proposals to bridge the gaps in care for gastric and gastroesophageal junction (GEJ) cancer patients in the United States.

Letter of Intent Due: October 24, 2018



Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01/R21)

The purpose of this FOA is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations.

Application Deadline: October 24, 2018



Tobacco Use and HIV in Low and Middle Income Countries (R01)

The purpose of this FOA is to encourage research focused on tobacco use and HIV infection in low and middle income countries.

Application Deadline: November 1, 2018


 
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)

This  FOA calls for interdisciplinary collaborations across scientific  disciplines engaged in microbiome and pro/prebiotic research. 

Application Deadline: November 5, 2018


Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 5, 2018



The Role of Epitranscriptomics in Development and Disease 

The purpose of this FOA is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. 

Application Deadline: November 7, 2018

 
Feasibility Studies to Build Collaborative Partnerships in Cancer Research

This FOA invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs)

Application Deadline: November 14, 2018



Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers

The purpose of this FOA is to facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in HIV-infected individuals.

Application Deadline: November 15, 2018


Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 16, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html



Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine

The purpose of this FOA is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.

Application Deadline: November 19, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-841.html 


Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

The purpose of this FOA is to promote the discovery of strong candidate biomarkers and endpoints  for pain that can be used to facilitate the development of non-opioid  pain therapeutics from discovery through Phase II clinical trials. 

Application Deadline: November 27, 2018



Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U54 and U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to establish centers of collaborating investigators with the goal of identifying and  advancing research opportunities for translating immunotherapy concepts  for children and adolescents with cancer toward clinical applications.

Application Deadline: December 17, 2018

 
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) 

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to increase case ascertainment and appropriate follow-up care, optimizing the  delivery of evidence-based healthcare for individuals at high risk of  cancer due to an inherited genetic susceptibility. 

Application Deadline: January 9, 2019 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-017.html 


NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

This FOA invites grant applications for the Research  Specialist Award (R50) in any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Through this FOA, the NCI invites grant applications for the Research Specialist Award (R50) in  any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants.  

Women’s Health Research at Yale Pilot Project Grants

On behalf of Dr. Carolyn M. Mazure and WHRY, we are pleased to announce the availability of Pilot Project Grants with awards starting July 1, 2019. All Yale Ladder Faculty are eligible to apply. Investigators outside the Yale community are invited to collaborate with Yale or Yale-affiliated principal investigators.

Letter of Intent Due: October 25, 2018



Nominations for Annual YCC Awards

Yale Cancer Center is pleased to announce our call for nominations for our annual awards in the areas of excellence in research and clinical care. Research Prizes will be awarded in support of excellence in the areas of basic science, clinical research, translational research, and cancer prevention and control. To be eligible you must be either the first or last author of the publication. Email your publication to anna.raso@yale.edu

Nomination Deadline: October 26th, 2018

2019 Szent-Gyorgyi Prize for Progress in Cancer Research

The Prize was established to honor an outstanding researcher whose  scientific achievements have expanded our understanding of cancer and  cancer causation. Nominations may be made by individuals from the research community, industry, government, or other organizations who are sufficiently familiar with the research  accomplishments and contributions of the nominee.

Internal Application Deadline: September 20, 2018
Sponsor Nomination Deadline: September 30, 2018

https://yalecancercenter.submittable.com/submit/5e4d6700-193a-4e7c-9fe3-22fe77ddab99/2019-szent-gyorgyi-prize-for-progress-in-cancer-research

Applications for the Yale Cancer Center K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Awards

We are pleased to solicit applications for the Yale Cancer Center (YCC) K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Award for junior faculty to enhance research skills beyond the training provided during graduate and postgraduate training. Successful applicants are required to demonstrate a strong commitment to a career in cancer immunology.  The two-year IOTP curriculum includes didactic and practical training in basic, translational and clinical aspects of cancer immunology research. The program also includes a required research component (either clinical or bench research, or a combination thereof). Applicants will be funded for up to 75% effort and can receive up to $27,800 per year for research expenses. Applicants are required to identify a mentor and a provide a research and mentorship proposal. For additional information and questions, please contact Meina Wang, PhD (meina.wang@yale.edu) or Harriet Kluger, MD (harriet.kluger@yale.edu).
 
Application Deadline: December 1, 2018 at 5:00 PM EST



Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to Luminary@ynhh.org